SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-22-015503
Filing Date
2022-06-21
Accepted
2022-06-21 17:14:02
Documents
15
Period of Report
2022-06-20
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K inbp20220620_8k.htm   iXBRL 8-K 41775
2 EXHIBIT 99.1 PRESS RELEASE FOR CHANGE IN DIRECTORS ex_388561.htm EX-99.1 8029
7 ex_388561img001.jpg GRAPHIC 7330
  Complete submission text file 0001437749-22-015503.txt   185767

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA inbp-20220620.xsd EX-101.SCH 3601
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inbp-20220620_def.xml EX-101.DEF 10449
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE inbp-20220620_lab.xml EX-101.LAB 13928
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inbp-20220620_pre.xml EX-101.PRE 10440
9 EXTRACTED XBRL INSTANCE DOCUMENT inbp20220620_8k_htm.xml XML 2314
Mailing Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205
Business Address 225 LONG AVENUE BUILDING 15 HILLSIDE NJ 07205 9739260816
INTEGRATED BIOPHARMA INC (Filer) CIK: 0001016504 (see all company filings)

IRS No.: 222407475 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-31668 | Film No.: 221029022
SIC: 2834 Pharmaceutical Preparations